KOD logo

Kodiak Sciences Inc Common Stock


KOD: Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.


Show KOD Financials

Consumer Interest
SEC Filings

Recently reported changes by institutional investors

Quarterly net insider trading by KOD's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of KOD in WallStreetBets Daily Discussion

KOD News

Recent insights relating to KOD

CNBC Recommendations

Recent picks made for KOD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in KOD

Corporate Flights

Flights by private jets registered to KOD